532523:BOM
Biocon Ltd
₹350.00
arrow_downward
-0.43%(-1.50) 1D
Okt 16, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 532523...
Buksan
₹352.95
Mataas
₹352.95
Mababa
₹348.10
Mkt. cap
568.79B
Avg. na dami
692.61K
Dami
668.34K
Dividend
0.14%
Bawat tatlong buwang dividend
₹0.13
Petsa ng ex-dividend
Hul 3, 2026
P/E ratio
103.62
Mataas nang 52-wk
₹447.00
Mababa nang 52-wk
₹337.95
EPS
₹3.38
Mga natitirang share
600.00M
Bilang ng mga empleyado
16K
Buksan
₹352.95
Mataas
₹352.95
Mababa
₹348.10
Mkt. cap
568.79B
Avg. na dami
692.61K
Dami
668.34K
Dividend
0.14%
Bawat tatlong buwang dividend
₹0.13
Petsa ng ex-dividend
Hul 3, 2026
P/E ratio
103.62
Mataas nang 52-wk
₹447.00
Mababa nang 52-wk
₹337.95
EPS
₹3.38
Mga natitirang share
600.00M
Bilang ng mga empleyado
16K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Motley Fool
·
7 oras ang nakalipas
The 10-Year Treasury Is Above 5% for the First Time in Almost 20 Years. History Says This Is How the S&P 500 Index Will Perform Over the Next 12 Months.
Bloomberg.com
·
53 minuto ang nakalipas
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
24/7 Wall St.
·
5 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
FXStreet
·
3 araw ang nakalipas
Dow Jones futures gains ahead of US PPI, Retail Sales data
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Tungkol sa Biocon Ltd
CEOShreehas P Tambe
Mga Empleyado16.4K
ItinatagNob 29, 1978
HeadquartersBangalore, Karnataka, India
Sektor-
Websitebiocon.com